Literature DB >> 19209736

[The surveillance of communicable diseases within the International Health Regulations (2005)].

Agnieszka Kicman-Gawłowska1.   

Abstract

On the 15th of June 2007 entered into force the International Health Regulations entered into force with are the revision previous Health Regulations from 1969. The IHR (2005) were adopted on 58 World Health Assembly by WHO member-states. The new Regulations give a new opportunity and tools to protect and control of infections diseases. Because of a broad scope, IHR (2005) are also useful in detection of any event that may constitute a public health risk. The key terms as defined by IHR (2005) are: term of event, disease, public health risk (PHR), public health emergency of international concern (PHEIC), National IHR Focal Point and WHO IHR Contact Point. By new requirements State-Parties are involve in real time event management, they are also oblige to asses the event risk according to decision instrument in Annex 2 of IHR (2005). This article reviews the key obligations of IHR (2005) to both member-states and WHO and also the ways of emergence communications under this document.

Entities:  

Mesh:

Year:  2008        PMID: 19209736

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  2 in total

1.  The implementation of Integrated Disease Surveillance and Response in Uganda: a review of progress and challenges between 2001 and 2007.

Authors:  Luswa Lukwago; Miriam Nanyunja; Nestor Ndayimirije; Joseph Wamala; Mugaga Malimbo; William Mbabazi; Anne Gasasira; Immaculate N Nabukenya; Monica Musenero; Wondimagegnehu Alemu; Helen Perry; Peter Nsubuga; Ambrose Talisuna
Journal:  Health Policy Plan       Date:  2012-06-04       Impact factor: 3.344

2.  Lessons learnt from implementation of the International Health Regulations: a systematic review.

Authors:  Amitabh B Suthar; Lisa G Allen; Sara Cifuentes; Christopher Dye; Jason M Nagata
Journal:  Bull World Health Organ       Date:  2017-12-11       Impact factor: 9.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.